When considering the long-term future of the company, consider its growing, embedded positioning in America's schools as a strong positive.
This fuel has been out of favor for almost 2 years, but the sector could be poised for a technical rally.
Wall Street has misunderstood the mining company's acquisition of two energy producers, says one expert.
New investors can pick up shares of the tech giant now without paying a premium for growth.
The $510 million acquisition of YM BioSciences is a low-risk deal for the big biotech, and has Incyte shareholders worried.
Is it time for the all-American restaurant to make a push in China?
Analysts expect pomalidomide will win US approval in February, adding a potential blockbuster treatment to the biotech's drug lineup.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Joe Cantrell says he faces charges after trying to take advantage of the retailer's policy.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.